Innovation -
From Molecule to Market
Sanign Laboratories is a pharmaceutical R&D organization that provides an integrated platform for the design, synthesis and development of high-value complex pharmaceutical molecules such as APIs, chiral intermediates, super generics, NMEs and NCEs.
Infrastructure
The company has established a one-of-its-kind R&D centre in Jammu, housing chemistry labs for organic synthesis and an analytical facility. We are elevating our R&D footprint by setting up biocatalysis and phytochemistry facilities and a kilo lab for scale-up and generation of multi-kilo material, transforming a standard bench-scale laboratory into a highly integrated, modern process development and scale-up hub.
Our Facilities
-
01
R&D Labs
The company has established a one-of-its-kind R&D centre in Jammu, housing chemistry labs for organic synthesis and an analytical facility.
-
02
Kilo Lab Facility
A kilo lab for scale-up and generation of multi-kilo material, transforming a standard bench-scale laboratory into a highly integrated, modern process development and scale-up hub is being set up.
-
03
Biocatalysis & Phytochemistry Facility
We are elevating our R&D footprint by setting up biocatalysis and phytochemistry (extraction, isolation and standardization of plant extracts) facilities.
Leadership
The people driving innovation at Sanign Laboratories

Dr Rajesh Kumar Thaper
Dr Thaper, a PhD from Zelinsky Institute of Organic Chemistry, Moscow, has held several senior R&D positions as director/HOD in leading pharmaceutical organizations like Ranbaxy, Lupin, Dr Reddy’s and Jubilant. He brings over three decades of experience in technology, innovation and execution.
With expertise in API process development, chiral synthesis, biocatalysis and scale-up, and experience of heading large scientific teams, he has made significant contributions to the pharmaceutical industry. He has over 120 patents and several scientific publications to his credit. He serves on the board of, and as consultant to, a couple of pharma companies, is recognized as a PhD guide by several universities, and has developed extensive industry connections and networks.
Co-founders

Madhavan Singh Bains
A young entrepreneur who studied industrial engineering at BMS College of Engineering after schooling at Lawrence School Sanawar, Kasauli. Active in business since 2016, he has implemented an ERP system streamlining finance, warehouse management, purchase and taxation. He brings 9 years of experience to the organization.

Prabhu Pratap Singh Bains
A young entrepreneur handling sales, the retail segment and industry-related sales projects for his family business. He completed his BSc and management studies in 2022 at Bristol University, UK, after schooling at St George’s College, Mussoorie, and brings work experience from Inditex in the UK.
What we do
Our R&D based business is organised into three categories.
Contract research
Process development of APIs and intermediates, non-infringing process technologies and custom synthesis for pharmaceutical and chemical companies ...
More
Process development of APIs and intermediates, non-infringing process technologies, partnering for Paragraph IV filings and custom synthesis for domestic and multinational pharmaceutical and chemical companies. Gram-scale samples of NMEs are made under long-term partnerships for early toxicology studies and product launch, supporting innovators during their drug discovery programmes, especially phase-1 clinical trials. We also give generic companies the extra R&D support they need to bring speed, cost advantage and a USP to critical launches.
CDMO process development
R&D services for complex APIs and innovative technologies, for generic and innovator companies alike ...
More
R&D services for complex APIs and innovative technologies, for generic and innovator companies alike. Multinational generic companies look for trusted partners in India who bring speed and innovation to timely launches. We are building core competence in technologically complex and sensitive products, difficult-to-mimic generics, fermentation-based semi-synthetic APIs, NMEs, differentiated products and super generics, applying green chemistry and biocatalysis for cost-effective, environment-friendly and sustainable manufacturing.
Products and processes
Chiral intermediates and APIs, and the isolation and semisynthesis of phytomolecules from natural sources ...
More
Chiral intermediates and APIs: enzymes applied to build cost-effective, environment-friendly semisynthesis routes for high-value, complex molecules. Isolation and semisynthesis of phytomolecules: unlocking the potential of natural products from medicinal plants and other natural sources to create value.
Why engage us?
We are building a quiet and trusted chemistry process engine. Our “brains” and “labs” work in tandem.
- 30+ years of R&D experience and competence in process development
- Compliance and credibility are non-negotiable for us
- Confidentiality agreements (NDA)
- Clear IP ownership clauses
- Data integrity: lab notebooks, documentation and more
- "Will-this-be-a-success" analysis for the plant, with R&D solutions
- Chemistry-driven segmentation, QbD thinking, troubleshooting, CTP, CTQ, CPP and reproducibility
- Soon introducing an AI-assisted process development approach
Typical engagement model
Model
FTE basis and sponsored projects
Pricing
Fixed + success based fee
Pricing basis by service